ENSYSCE BIOSCIENCES, INC.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents
Accounts Receivable
Inventory
Total Current Assets $2.3M
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $202.4M
Liabilities
Accounts Payable $112.0K
Total Current Liabilities $156.2K
Long-Term Debt
Total Liabilities $12.8M
Stockholders' Equity
Retained Earnings $-1.1M
Total Stockholders' Equity $5.0M
← Newer Page 2 of 2 Older →